BioWorld MedTech

July 15, 2013

Panel discusses impact of ACA on both healthcare delivery, cost

Potential impacts of the Affordable Care Act (ACA), specifically regarding healthcare delivery and costs, were the topics of discussion for RBC Capital Markets, as the firm held a conference call late last week. Read More

Asia in the Spotlight: Diagnostic imaging market seen rapidly growing in Asia

CoreValve sales have been blocked by German court

Washington roundup: Finite element analysis now the tool of choice for virtual design

International report: SpinalCyte adds its first Japanese patent to portfolio

New ventures: Excellence Headquarters, MedSynergies form new JV

Agreements/contracts: C2N gains access to CIL's stable isotopes

Grants roundup: Auxogyn wins GFI award for embryo viability test

Financings roundup: Accelerate Diagnostics reports terms of $20M rights offering

HIT roundup: HUP installs LiveData OR-Dashboard in its ORs

Med-Tech Notes

People in the News

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...

Genescience presents STAT6 degrader for atopic dermatitis

BioWorld Science

Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....

Sangamo presents primate data for prion suppressor ST-506

BioWorld Science

Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...